Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1
| Autor: | Montemurro, Filippo, Ellis, Paul, Anton, Antonio, Wuerstlein, Rachel, Delaloge, Suzette, Bonneterre, Jacques, Quenel-Tueux, Nathalie, Linn, Sabine C., Irahara, Natsumi, Donica, Margarita, Lindegger, Nicolas, Barrios, Carlos H. |
|---|---|
| Zdroj: | In European Journal of Cancer March 2019 109:92-102 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect